Attention javascript est désactivé sur votre poste.
Ce site nécessite l'activation de javascript pour fonctionner correctement.
Follow our news on LinkedIn
Learn more
Follow our news on LinkedIn
Learn more
Our pipeline
OPM 101
OPM 102
OPM 201
COMETE
Partnering
Scientific news
Our innovation technologies
OncoSNIPER
Nanocyclix®
PROMETHE®
Investors
Message from the President
Investor Day 2023
Regulated informations [FR]
Press Releases
General Meetings [FR]
About us
Latest news
Our history
Management
Our HR policy
FederAidd
PROMETHE sector
CSR
Our approach
Our code of ethics and business conduct
Our carbon footprint
Contact us
The latest news of OPM are here
Subscribe to the OPM newsletter
Subscribe to the OPM newsletter
All
Financial
News
Poster
Press Release
Scientific paper
Uncategorized
Filter by :
All
Financial
News
Poster
Press Release
Scientific paper
Uncategorized
News
Press Release
Tue. 8 February 2022
SEngine Precision Medicine and Oncodesign Announce a Collaboration Agreement
Read more
Scientific paper
Thu. 6 January 2022
OncoSNIPE® Study Protocol
Read more
News
Press Release
Thu. 21 October 2021
Oncodesign and TiumBio sign a collaboration agreement
Read more
Press Release
Thu. 24 June 2021
Oncodesign provides an update on its progress on RIPK2
Read more
Scientific paper
Sat. 12 June 2021
Inhibiting Endothelial Cell Function in Normal and Tumor Angiogenesis Using BMP Type I Receptor Macrocyclic Kinase Inhibitors
Read more
News
Tue. 18 May 2021
InterSystems and Oncodesign partner for the optimization of data use
Read more
Poster
Tue. 1 September 2020
NANOCYCLIX® ALK2 INHIBITORS TO OVERCOME CANCER INDUCED ANEMIA
Read more
Scientific paper
Mon. 7 October 2019
Development of Macrocycle Kinase Inhibitors for ALK2 Using Fibrodysplasia Ossificans Progressiva-Derived Endothelial Cells
Read more
1
2
3
4